Resistance Profile of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Abacavir (1592U89) after Monotherapy and Combination Therapy
Open Access
- 1 March 2000
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 181 (3) , 912-920
- https://doi.org/10.1086/315317
Abstract
Abacavir (1592U89) is a nucleoside inhibitor of human immunodeficiency virus (HIV) type 1 reverse transcriptase (RT). Resistance to abacavir was studKeywords
This publication has 0 references indexed in Scilit: